Clinical market

This company founded in 1994, is a contract molecular biology and screening service company for the pharmaceutical, research, and clinical markets worldwide. Custom services include gene synthesis, DNA sequencing, site-directed mutagenesis, nucleic acid purification, and genotype/genetic analysis. 

Whilst specifically developed for the clinical market, the Cobas Fara II has many other areas of apphcation, for example in environmental testing, food testing and animal toxicology. 

For an automatic method to be preferable purely on economic grounds, its cost must be less than the manual cost by at least an amount equal to the cost of the automatic equipment amortized over a period of three to five years. For many of the more expensive instruments, particularly those in the clinical market, leasing agreements are common and in these cases the annual cost must be less for the automated regime. However, this simple algebraic treatment is very approximate and takes no account of the differences in reagent costs, power requirements, and supervisory cost between the two methods. 

Assurance (QA), Clinical, Marketing, and all other parts of the organization. In-house experience and diverse expertise will allow you to prevent or solve problems when they arise. 

Such microelectronic biosensor systems are really microanalytical sensor systems which have already reached the clinical market. 

Competing perspectives create tension, for example pharmacoeconomics versus clinical importance. Differences in perspective may be irreconcilable because they relate to a perceived encroachment turf wars can erupt between clinical, marketing and pharmacoeconomics departments within the same company, in spite of all three professing the same goal, that is to successfully market a worthwhile drug in a proper fashion. 

Technical issues and inadequate QC measures in the early microarray studies brought about serious concerns and criticisms about the reproducibility of the micro array data provided as well as their biological interpretations inferred. These shortcomings in the microarray techniques themselves, as well as the harsh competition from other molecular diagnostic techniques, deter success in the clinical market as they were in the research counterparts. 

Table 3.4 An Overview of the Clinically Marketed Hg-R Antagonists Affinity, Clinical Pharmacology, and Pharmacokinetic Profile "... 

Experience has shown that it is most efficient to intervene early in the discovery process. This is when discovery teams traditionally have the least amount of information available for making decisions. Informed decisions at this stage have the greatest leverage on productive downstream work. Correct choice of one or more lead series at this stage can make later work more successful. Conversely, lack of information at this stage can lead to investment of time and resources in a compound series that is later found to have a fatal flaw. This is demoralizing for the team, wasteful of resources, and leads to later entry into the clinical market. 

The main fields of applications for SFA systems are, in order of current importance, water, soil and plant extracts, tobacco, food and beverages, chemical production, and clinical analysis. The reasons for the decline of the formerly dominant clinical market have been described pharmaceutical applications, also previously important, have declined because standard methods developed for new products are generally based on separative techniques, especially liquid chromatography (LC). Table 1 shows the most common applications of SFA. 

Clinical applications of the systems described in this chapter are still very hmited. Nevertheless, it is expected that the intense research effort focused on these technologies will produce significant contributions to make this systems fully available in the clinical market within the coming years. This section highlights the opportunities and promising applications of smart instructive biomaterials in TE. 

---